MedTrace Logo

The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation Lesions

NCT02127138 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2020-01-18

No results posted yet for this study

Summary

A Prospective Multi-center Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Unprotected Distal Left Main Bifurcation Lesions

Conditions

Interventions

DEVICE

Sirolimus eluting Drug stent

Use the Sirolimus-eluting Drug stents has been approved by the CFDA，But does not allow use taxol-eluting Drug stents and Drug-eluting stent without Polymer.

Sponsors & Collaborators

  • Beijing Jishuitan Hospital

    collaborator OTHER

  • Tianjin First Central Hospital

    collaborator OTHER

  • Tianjin Chest Hospital

    collaborator OTHER

  • Taihe Hospital

    collaborator OTHER

  • The Fourth Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • General Hospital of Ningxia Medical University

    collaborator OTHER

  • Tangshan Worker's Hospital

    collaborator OTHER

  • Beijing Anzhen Hospital

    lead OTHER

Principal Investigators

  • Yujie Zhou, MD, PhD · Beijing Anzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02127138 on ClinicalTrials.gov